ADC Therapeutics SA (ADCT) is a publicly traded Healthcare sector company. As of May 21, 2026, ADCT trades at $3.49 with a market cap of $403.20M and a P/E ratio of -3.25. ADCT moved +3.18% today. Year to date, ADCT is -8.99%; over the trailing twelve months it is +50.70%. Its 52-week range spans $1.05 to $4.98. Analyst consensus is strong buy with an average price target of $8.00. Rallies surfaces ADCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent ADCT insider activity includes Redmile Group, LLC sold 2.63M, Redmile Group, LLC sold 2.53M, Redmile Group, LLC sold 169.26K, Redmile Group, LLC sold 162.52K, and Redmile Group, LLC sold 196.23K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $3.49 |
| Market Cap | $403.20M |
| P/E Ratio | -3.25 |
| EPS | $-0.99 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.98 |
| 52-Week Low | $1.05 |
| Volume | 592.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $79.17M |
| Net Income | $-136.99M |
| Gross Margin | 0.00% |
3 analysts cover ADCT: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.00.